RB1 and neoplasm: Intriguingly, similar to BJ-T and BJ-T p53sh cells, CX-5461 treatment induced a proliferation defect in the BJ-LSTR cells despite SV40-mediated inactivation of the p53 and retinoblastoma protein (RB) families of tumour suppressors (Figure S3A).